EMA Authorised: Oncaspar (pegaspargase) — Les Laboratoires Servier

View source ↗

Summary

The European Medicines Agency authorised Oncaspar (pegaspargase) from Les Laboratoires Servier for precursor cell lymphoblastic leukemia-lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Precursor Cell Lymphoblastic Leukemia-lymphoma

Drugs mentioned

• Oncaspar (pegaspargase)

Snippet

Status: Authorised. Therapeutic area: Precursor Cell Lymphoblastic Leukemia-Lymphoma. MAH: Les Laboratoires Servier. Decision date: 16/05/2024